FDA Approves Alymsys® (bevacizumab-maly), a Biosimilar of Bevacizumab by Amneal Pharmaceuticals, Inc., developed by mAbxience
Insud Pharma and Fresenius Kabi combine efforts to accelerate the growth of mAbxience
Cipla enters partnership to provide affordable oncology biosimilars to South Africa
